Neurologists report discomfort in telling patients that they do not actually have MS.
Efforts to diagnose multiple sclerosis (MS) earlier, using simplified criteria, sometimes lead to misdiagnosis. To learn about how physicians handle this dilemma, investigators e-mailed surveys to 242 neurologists with an active MS practice.
Most of the 122 respondents had long-standing experience in treating MS, had completed an MS fellowship, and worked at a U.S. academic MS center. Of the 95% of respondents who within the past year had evaluated a patient they “strongly felt did NOT in fact have MS,” a plurality had seen three to five such patients. Alternative diagnoses included nonspecific white-matter abnormalities, small-vessel ischemic disease, migraine, psychiatric disease, neuromyelitis optica, and fibromyalgia.
Most respondents fou…
Reviewing Author
DisclosuresConsultant/Advisory BoardAlexion Pharmaceuticals; Amgen; Astoria; Biogen; Bristol Myers Squibb; Celltrion; Genentech; Hoffmann-La Roche; Genzyme; EMD Serono; Immpact-Bio; Immunic Therapeutics; Kyverna; Lundbeck; Novartis; Sandoz; TG Therapeutics
Grant/Research SupportNational Institutes of Health; National Multiple Sclerosis Society; U.S. Department of Defense
Leadership Positions in Professional SocietiesConsortium of Multiple Sclerosis Centers (Treasurer)
DisclosuresConsultant/Advisory BoardAlexion Pharmaceuticals; Amgen; Astoria; Biogen; Bristol Myers Squibb; Celltrion; Genentech; Hoffmann-La Roche; Genzyme; EMD Serono; Immpact-Bio; Immunic Therapeutics; Kyverna; Lundbeck; Novartis; Sandoz; TG Therapeutics
Grant/Research SupportNational Institutes of Health; National Multiple Sclerosis Society; U.S. Department of Defense
Leadership Positions in Professional SocietiesConsortium of Multiple Sclerosis Centers (Treasurer)